Ablation therapy for kidney cancer
Ablation therapy is a procedure that destroys cancer cells, while preserving as much of the surrounding tissue as possible. It isn’t used very often to treat kidney cancer. It works best on smaller tumours (less than 3 cm in diameter).
For kidney cancer, ablation therapy may be used to:
- treat people who aren’t healthy enough to have surgery to remove a tumour
- control pain or bleeding from a tumour that can’t be removed with surgery
- treat people who only have one working kidney
Ablation therapies may also be offered to people with certain inherited genetic conditions that increase the risk of developing different types of kidney cancer. People with these genetic conditions often have several tumours in both kidneys. Ablation therapies allow doctors to preserve as much kidney function as possible.
How ablation therapy is done
Ablation therapy for kidney cancer is done in one of the following ways:
Percutaneous ablation therapy uses an ultrasound or a CT scan to guide an instrument though the skin and muscle of the abdominal wall, directly into tumours in the kidney.
Laparoscopic ablation therapy is done through narrow incisions, or cuts, in the abdominal wall. The doctor uses special instruments to reach the tumours. Tumours close to surrounding organs can be more easily treated using the laparoscopic method.
Open, or surgical, ablation therapy is done through a cut in the abdominal wall to reach the kidney. The doctor then puts instruments into the tumours in the kidney. This method is best for treating larger or multiple tumours.
You may need to have several treatment sessions. After an ablation treatment is complete, a CT scan is used to see if the tumours have shrunk or if more treatment is needed.
Types of ablation therapy
The following ablation therapies are used for kidney cancer.
Radiofrequency ablation (RFA) is the type of ablation therapy most commonly used for kidney cancer. During RFA, a high-frequency electrical current creates heat that is used to destroy cancer cells. The electrical current is delivered directly into the tumour by a thin needle, which is guided by ultrasound or CT scan. Local or general anaesthesia may be used during RFA.
The heat from the needle used in RFA may damage healthy tissues around the tumour. RFA is not used for tumours that are deep inside the kidney because it may damage the renal pelvis and collecting ducts.
Cryoablation is a procedure that destroys cancer cells by freezing them. It is also called cryosurgery, cryosurgical ablation or cryotherapy.
Cryoablation delivers an extremely cold liquid or gas to the tissues of the kidney through a metal tube called a cryoprobe. The doctor uses ultrasound to guide the cryoprobe to the tumour. The area is allowed to thaw and then is frozen again. The freeze-thaw cycle may need to be repeated a few times.
Cryosurgery works best for small kidney tumours. It is used more often than RFA on kidney tumours deep inside the kidney because it causes less damage to the renal pelvis.
Side effects can happen with any type of treatment for kidney cancer, but everyone’s experience is different. Some people have many side effects. Other people have few or none at all.
Side effects can develop any time during, immediately after or a few days or weeks after ablation therapy. Most side effects will go away on their own or can be treated, but some may last a long time or become permanent.
Side effects of ablation therapy will depend mainly on the type of ablation therapy, how the ablation therapy is done, and your overall health. Some common side effects for ablation therapy are:
Tell your healthcare team if you have these side effects or others you think might be from your ablation therapy. The sooner they are aware of any problems, the sooner they can suggest ways to help you deal with them.
Taking action against all cancers
The latest Canadian Cancer Statistics report found that of all newly diagnosed cancers in 2017, half are expected to be lung, colorectal, breast and prostate cancers. Learn what you can do to reduce the burden of cancer.